Categories: Healthcare, Pharmaceutical, Medical Devices, and Biotechnology | Report Code : HPMDB20 | No. of Pages : 130
Overview:
Renal denervation (RDN) is technologically advanced system for treatment of resistant hypertension. It is a minimally invasive procedure focused on use of radiofrequency ablation to burn nerves in the renal arteries. Resistant hypertension usually refers to high blood pressure which with the help of radiofrequency ablation the nerve activity is reduced further decreasing the blood pressure.
Market Dynamics:
Gradual increasing in number of patients suffering from therapy-resistant hypertension across the globe and rapid technological advancements in therapy techniques are major factors expected to drive growth of the global renal denervation market. In addition, increasing geriatric population in developing countries and increasing demand for minimally invasive therapy are among other factors expected to support growth of the target market.
Business development activities by major players in order to enhance the customer base and increase the revenue through merger and acquisitions are other factors expected to boost growth of the target market. In addition, increasing healthcare expenditure by government of developing countries, changing regulatory scenario, and players approach towards tracking untapped market in emerging economies are factors expected to augment growth of global market during the forecast period.
Key Trends:
Major players approach towards product innovation and introduction of innovative solutions is the key trend observed in the target market. In 2018, Medtronic - a medical device company received approval from the FDA in order to start investigational device exemption (IDE) trials in patients with hypertension in order to evaluate the symplicity spyral renal denervation system.
Regional Analysis:
For detailed understanding of market dynamics, the global renal denervation market is analyzed across key regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America accounted for the major revenue share in 2018, owing to increasing number of patients suffering from hypertension. In addition, high investment by major players for R&D activities and high government spending for the development of healthcare infrastructure in order to facilitate the adoption of advanced devices are among other factors expected to further support the growth of regional market.
Scope of the Report:
Report Feature |
Details |
Base Year: |
2018 |
Projection Period: |
2019-2029 |
Market Details: |
Total revenue and forecast, CAGR, Market value, share, and Y-o-Y growth by segment and region |
Segment Covered: |
Product, Technology, and End Use |
Region Covered: |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Report Coverage: |
Market growth driving factors, challenges & pitfalls, opportunities, trends, key players analysis, and region analysis |
Detailed Segmentation:
Global Renal Denervation Market, By Product:
Global Renal Denervation Market, By Technology:
Global Renal Denervation Market, By End Use:
Key Players Covered:
Key players operating in the market includes, Abbott Laboratories; Ablative Solutions, Inc.; Renal Dynamics; Mercator MedSystems, Inc.; Medtronic PLC; Cardiosonic, Inc.; Kona Medical, Inc.; ReCor Medical, Inc.; Boston Scientific Corp.; and Symple Surgical, Inc.
Key features of the study:
Foresight Market Research provides detailed analysis on global market in our report- Global Renal Denervation Market by product, technology, end use, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, and regional outlook. The report delivers competitive analysis about leading players in the global renal denervation market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe.